| scholarly article | Q13442814 |
| P2093 | author name string | Keiji Yoshinaga | |
| Manabu Yamamoto | |||
| Ayumi Matsuyama | |||
| Teruyoshi Ishida | |||
| Shinichi Tsutsui | |||
| Tokiomi Iwasa | |||
| P2860 | cites work | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 |
| Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine | Q28255790 | ||
| Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world | Q29614969 | ||
| Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study | Q31081052 | ||
| 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer | Q33487198 | ||
| A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). | Q33491452 | ||
| Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer | Q34366342 | ||
| Epidemiology of gastric cancer in Japan | Q34559042 | ||
| S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial | Q34588472 | ||
| CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment | Q35193958 | ||
| Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma | Q36615597 | ||
| Docetaxel in the treatment of gastric cancer | Q36616503 | ||
| Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). | Q40613157 | ||
| Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293. | Q40667282 | ||
| Preliminary trial of adjuvant surgery for advanced gastric cancer | Q42323722 | ||
| Neoadjuvant chemotherapy combining docetaxel, cisplatin and S-1 in gastric cancer with para-aortic lymph node metastases: report of five cases. | Q42744507 | ||
| A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703) | Q42915833 | ||
| Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study | Q43264239 | ||
| Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer | Q44993315 | ||
| Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases. | Q45960156 | ||
| Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer. | Q46134832 | ||
| Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. | Q53604465 | ||
| Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer | Q83895070 | ||
| Japanese classification of gastric carcinoma: 3rd English edition | Q84106763 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 662-666 | |
| P577 | publication date | 2011-12-14 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Preliminary trial of surgery after chemotherapy for advanced gastric cancer with peritoneal dissemination | |
| P478 | volume | 3 |
| Q37513926 | Laparoscopic gastrectomy for gastric cancer with peritoneal dissemination after induction chemotherapy | cites work | P2860 |
Search more.